Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0000950170-24-106612
Filing Date
2024-09-16
Accepted
2024-09-16 08:07:16
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 korro_preclosingprosuppp.htm 424B3 59384
2 GRAPHIC img237592423_0.jpg GRAPHIC 2509
  Complete submission text file 0000950170-24-106612.txt   64127
Mailing Address 60 FIRST STREET 2ND FLOOR, SUITE 250 CAMBRIDGE MA 02141
Business Address 60 FIRST STREET 2ND FLOOR, SUITE 250 CAMBRIDGE MA 02141 617-468-1999
Korro Bio, Inc. (Filer) CIK: 0001703647 (see all company filings)

EIN.: 472324450 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-275353 | Film No.: 241299381
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)